These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25403361)

  • 1. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples.
    Matranga CB; Andersen KG; Winnicki S; Busby M; Gladden AD; Tewhey R; Stremlau M; Berlin A; Gire SK; England E; Moses LM; Mikkelsen TS; Odia I; Ehiane PE; Folarin O; Goba A; Kahn SH; Grant DS; Honko A; Hensley L; Happi C; Garry RF; Malboeuf CM; Birren BW; Gnirke A; Levin JZ; Sabeti PC
    Genome Biol; 2014; 15(11):519. PubMed ID: 25403361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbiased Deep Sequencing of RNA Viruses from Clinical Samples.
    Matranga CB; Gladden-Young A; Qu J; Winnicki S; Nosamiefan D; Levin JZ; Sabeti PC
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27403729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.
    Andersen KG; Shapiro BJ; Matranga CB; Sealfon R; Lin AE; Moses LM; Folarin OA; Goba A; Odia I; Ehiane PE; Momoh M; England EM; Winnicki S; Branco LM; Gire SK; Phelan E; Tariyal R; Tewhey R; Omoniwa O; Fullah M; Fonnie R; Fonnie M; Kanneh L; Jalloh S; Gbakie M; Saffa S; Karbo K; Gladden AD; Qu J; Stremlau M; Nekoui M; Finucane HK; Tabrizi S; Vitti JJ; Birren B; Fitzgerald M; McCowan C; Ireland A; Berlin AM; Bochicchio J; Tazon-Vega B; Lennon NJ; Ryan EM; Bjornson Z; Milner DA; Lukens AK; Broodie N; Rowland M; Heinrich M; Akdag M; Schieffelin JS; Levy D; Akpan H; Bausch DG; Rubins K; McCormick JB; Lander ES; Günther S; Hensley L; Okogbenin S; ; Schaffner SF; Okokhere PO; Khan SH; Grant DS; Akpede GO; Asogun DA; Gnirke A; Levin JZ; Happi CT; Garry RF; Sabeti PC
    Cell; 2015 Aug; 162(4):738-50. PubMed ID: 26276630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
    Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
    Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging intracellular receptors for hemorrhagic fever viruses.
    Jae LT; Brummelkamp TR
    Trends Microbiol; 2015 Jul; 23(7):392-400. PubMed ID: 26004032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QnAs with Pardis Sabeti.
    Ravindran S
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9757-9758. PubMed ID: 28874553
    [No Abstract]   [Full Text] [Related]  

  • 8. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time.
    Barnes KG; Lachenauer AE; Nitido A; Siddiqui S; Gross R; Beitzel B; Siddle KJ; Freije CA; Dighero-Kemp B; Mehta SB; Carter A; Uwanibe J; Ajogbasile F; Olumade T; Odia I; Sandi JD; Momoh M; Metsky HC; Boehm CK; Lin AE; Kemball M; Park DJ; Branco L; Boisen M; Sullivan B; Amare MF; Tiamiyu AB; Parker ZF; Iroezindu M; Grant DS; Modjarrad K; Myhrvold C; Garry RF; Palacios G; Hensley LE; Schaffner SF; Happi CT; Colubri A; Sabeti PC
    Nat Commun; 2020 Aug; 11(1):4131. PubMed ID: 32807807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N
    Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology. Emerging disease or diagnosis?
    Gire SK; Stremlau M; Andersen KG; Schaffner SF; Bjornson Z; Rubins K; Hensley L; McCormick JB; Lander ES; Garry RF; Happi C; Sabeti PC
    Science; 2012 Nov; 338(6108):750-2. PubMed ID: 23139320
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
    Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
    Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peripheral Blood Smears Made on Plastic Microscope Slides.
    Relich RF; Feldmann H; Haddock E
    Am J Trop Med Hyg; 2020 Nov; 103(5):2085-2090. PubMed ID: 32959767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.
    Mahanty S; Hutchinson K; Agarwal S; McRae M; Rollin PE; Pulendran B
    J Immunol; 2003 Mar; 170(6):2797-801. PubMed ID: 12626527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR; Guerrero LW; Chakrabarti AK; McMullan LK; Flint M; Bluemling GR; Painter GR; Nichol ST; Spiropoulou CF; Albariño CG
    Antiviral Res; 2016 Dec; 136():9-18. PubMed ID: 27771389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metavisitor, a Suite of Galaxy Tools for Simple and Rapid Detection and Discovery of Viruses in Deep Sequence Data.
    Carissimo G; van den Beek M; Vernick KD; Antoniewski C
    PLoS One; 2017; 12(1):e0168397. PubMed ID: 28045932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H
    Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral evolution: The history of Lassa virus.
    Attar N
    Nat Rev Microbiol; 2015 Oct; 13(10):600. PubMed ID: 26299786
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK
    Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
    Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
    J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.